会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 72. 发明授权
    • Dispersible concentrate lipospheres for delivery of active agents
    • 用于递送活性剂的可分散浓缩物脂质体
    • US07919113B2
    • 2011-04-05
    • US10965551
    • 2004-10-14
    • Abraham J. Domb
    • Abraham J. Domb
    • A61K9/127
    • A61K9/1075Y10S977/797Y10S977/799Y10S977/801
    • A formulation containing one or more lipophilic agents, methods of making and using the formulation are described herein. The formulation is formed by adding a pre-suspension concentrate composition to an aqueous medium. Upon contact with the aqueous medium, a solid nanoparticle suspension spontaneously forms. The resulting formulation is in the form of a microemulsion. The concentrate contains an amphiphilic solvent, a pharmaceutically acceptable solid carrier such as a solid fatty acid or ester, a surfactant, and an agent. Preferably the concentrate contains a combination of a surfactant with a high hydrophilic/lipophilic balance (HLB) of at least about 8 and a surfactant with a low HLB of less than about 5. The agent is preferably a lipophilic drug and other lipophilic ingredient, such as vitamins. The composition is suitable for use in medical and non-medical applications. The microemuslions described herein have increased stability was compared to the prior art.
    • 本文描述了含有一种或多种亲脂性试剂的制剂,制备和使用制剂的方法。 该制剂通过将预悬浮浓缩组合物加入到水性介质中而形成。 在与水性介质接触时,固体纳米颗粒悬浮液自发形成。 所得制剂是微乳液的形式。 浓缩物含有两亲溶剂,药学上可接受的固体载体如固体脂肪酸或酯,表面活性剂和试剂。 优选地,浓缩物含有具有至少约8的高亲水/亲油平衡(HLB)的表面活性剂和低HLB小于约5的表面活性剂的组合。该试剂优选是亲脂性药物和其它亲脂性成分,例如 作为维生素。 该组合物适用于医疗和非医疗应用。 与现有技术相比,本文所述的微型密封件具有增加的稳定性。
    • 76. 发明申请
    • ADHESIVE COMPOSITIONS FOR THE TREATMENT OF XEROSTOMIA
    • 用于治疗XEROSTOMIA的粘合剂组合物
    • US20090053309A1
    • 2009-02-26
    • US11959997
    • 2007-12-19
    • Abraham J. DombBenny Brama
    • Abraham J. DombBenny Brama
    • A61K9/20A61P1/00
    • A61K9/006A61K9/2086A61K31/22
    • Compositions and methods for the treatment of xerostomia are disclosed herein. Methods for making the compositions are also disclosed herein. The compositions are designed for individuals having the physiologic ability to salivate but who do not salivate in sufficient quantity to satisfy their personal comfort level of oral hydration. The compositions are typically in the form of a film or tablet, preferably in the form of a sticker tablet, most preferably in the form of a double layer sticker tablet, where one layer contains a bioadhesive material and the second layer contains the sialogogic agent and the one or more lipids. The compositions adhere to a buccal surface or mucosal surface in the oral cavity for at least 15 minutes, preferably for at least 30 minutes. The compositions contain a therapeutically effective amount of one or more sialogogic agents and one or more lipids for treating xerostomia and a pharmaceutically acceptable bioadhesive carrier. The compositions optionally contain a non-lipid lubricant, a flavoring agent, and/or a buffering agent. The methods for treatment of xerostomia require placing the composition on the oral mucosa of a patient's mouth, preferably on the palate or the cheek. The composition will adhere to the mucosal surface and dissolve over a period of time. The composition is generally effective at treating or ameliorating the effects of xerostomia for a time period ranging from at least 30 minutes up to 8 hours following administration to the buccal or oral mucosa.
    • 本文公开了用于治疗口腔干燥症的组合物和方法。 本文还公开了制备组合物的方法。 该组合物被设计用于具有唾液的生理能力但没有足够量的唾液以满足其个人舒适水平的口服水合的个体。 组合物通常为薄膜或片剂的形式,优选为贴片形式,最优选为双层贴片片剂的形式,其中一层包含生物粘附材料,第二层含有唾液酸剂, 一种或多种脂质。 组合物粘附在口腔中的口腔表面或粘膜表面至少15分钟,优选至少30分钟。 组合物含有治疗有效量的一种或多种唾液酸化剂和一种或多种用于治疗口腔干燥症的脂质和药学上可接受的生物粘附性载体。 组合物任选地含有非脂润滑剂,调味剂和/或缓冲剂。 用于治疗口腔干燥症的方法需要将组合物置于患者口腔的口腔粘膜上,优选在口腔或面颊上。 组合物将粘附到粘膜表面并溶解一段时间。 该组合物在施用至颊或口腔粘膜后至少30分钟至8小时的时间段内通常有效地治疗或改善口腔干燥症的作用。